ACC.26 advanced registration ends Feb. 12 – register now!

David Conen, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Roche Diagnostics(SIGNIFICANT) SPEAKER'S BUREAU: BMS/Pfizer(MODEST)

View Full Disclosure